Nuveen Asset Management, LLC Atri Cure, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,182,428 shares of ATRC stock, worth $34.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,182,428

Previous 1,373,944 13.94%

Holding current value

$34.8 Million

Previous $41.8 Million 35.58%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$19.86 - $29.09 $3.8 Million - $5.57 Million	-191,516 Reduced 13.94%	1,182,428 $26.9 Million
Q1 2024 May 13, 2024	BUY	$28.21 - $37.78 $9.91 Million - $13.3 Million	351,266 Added 34.35%	1,373,944 $41.8 Million
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $119,027 - $156,046	3,608 Added 0.35%	1,022,678 $36.5 Million
Q3 2023 Nov 14, 2023	BUY	$41.12 - $57.73 $1.56 Million - $2.19 Million	37,905 Added 3.86%	1,019,070 $44.6 Million
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $11.6 Million - $14.2 Million	286,481 Added 41.24%	981,165 $48.4 Million
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $5.81 Million - $7.65 Million	161,939 Added 30.4%	694,684 $28.8 Million
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $1.21 Million - $1.71 Million	36,019 Added 7.25%	532,745 $46.8 Million
Q3 2022 Nov 14, 2022	SELL	$38.25 - $52.62 $1.47 Million - $2.03 Million	-38,510 Reduced 7.19%	496,726 $19.4 Million
Q2 2022 Aug 15, 2022	BUY	$35.1 - $66.01 $1.49 Million - $2.79 Million	42,322 Added 8.59%	535,236 $21.9 Million
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $451,514 - $561,268	-7,862 Reduced 1.57%	492,914 $31.8 Million
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $4.18 Million - $5.74 Million	65,874 Added 15.15%	500,776 $34.8 Million
Q3 2021 Nov 12, 2021	BUY	$69.28 - $84.46 $270,469 - $329,731	3,904 Added 0.91%	434,902 $30.2 Million
Q2 2021 Aug 16, 2021	BUY	$64.13 - $80.18 $4.23 Million - $5.29 Million	66,029 Added 18.09%	430,998 $34.2 Million
Q1 2021 May 17, 2021	SELL	$53.79 - $66.98 $3.74 Million - $4.66 Million	-69,609 Reduced 16.02%	364,969 $23.9 Million
Q4 2020 May 17, 2021	BUY	$34.56 - $57.55 $3.29 Million - $5.47 Million	95,106 Added 28.02%	434,578 $24.2 Million
Q4 2020 Feb 16, 2021	SELL	$34.56 - $57.55 $3.35 Million - $5.57 Million	-96,843 Reduced 22.2%	339,472 $18.9 Million
Q3 2020 Nov 16, 2020	SELL	$38.36 - $46.91 $6.13 Million - $7.5 Million	-159,801 Reduced 26.81%	436,315 $17.4 Million
Q2 2020 Aug 14, 2020	SELL	$31.78 - $51.19 $1.37 Million - $2.21 Million	-43,094 Reduced 6.74%	596,116 $26.8 Million
Q1 2020 May 14, 2020	BUY	$24.49 - $43.84 $5.57 Million - $9.97 Million	227,431 Added 55.23%	639,210 $21.5 Million
Q4 2019 Feb 14, 2020	SELL	$24.06 - $32.51 $169,767 - $229,390	-7,056 Reduced 1.68%	411,779 $13.4 Million
Q3 2019 Nov 14, 2019	SELL	$23.81 - $32.52 $107,168 - $146,372	-4,501 Reduced 1.06%	418,835 $10.4 Million
Q2 2019 Aug 15, 2019	BUY	$26.85 - $30.74 $9.17 Million - $10.5 Million	341,689 Added 418.5%	423,336 $12.6 Million
Q1 2019 May 14, 2019	SELL	$26.38 - $33.34 $186,928 - $236,247	-7,086 Reduced 7.99%	81,647 $2.19 Million
Q4 2018 Feb 14, 2019	SELL	$26.66 - $34.85 $112,105 - $146,544	-4,205 Reduced 4.52%	88,733 $2.72 Million
Q3 2018 Nov 13, 2018	SELL	$27.62 - $35.58 $507,158 - $653,319	-18,362 Reduced 16.5%	92,938 $3.26 Million
Q2 2018 Aug 14, 2018	BUY	$19.65 - $30.28 $1.17 Million - $1.8 Million	59,593 Added 115.25%	111,300 $3.01 Million
Q1 2018 May 14, 2018	SELL	$15.05 - $21.03 $139,573 - $195,032	-9,274 Reduced 15.21%	51,707 $1.06 Million
Q4 2017 Feb 14, 2018	BUY	$17.69 - $23.44 $146,119 - $193,614	8,260 Added 15.67%	60,981 $0
Q3 2017 Nov 14, 2017	BUY	$20.0 - $24.23 $1.05 Million - $1.28 Million	52,721	52,721 $1.18 Million

Others Institutions Holding ATRC

# of Institutions

205

Shares Held

49.3M

Call Options Held

111K

Put Options Held

23.8K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.37B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Atri Cure, Inc. Transaction History